Affordable Sickle Cell Therapy Unveiled
India in November 2025 launched a domestically developed CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-based therapy, BIRSA-101, to provide an affordable cure for sickle cell anaemia, a hereditary blood disorder prevalent in tribal and rural regions, Jagat Prakash Nadda, Union minister for health and family welfare, told the Lok Sabha. Under the , screening is…